Clonal Hematopoiesis-Driven Inflammation: Cell Populations and Mechanisms
TET2-mutant and DNMT3A-mutant monocytes/macrophages are the primary clonal cell populations driving inflammation in clonal hematopoiesis, predominantly through IL-1β, IL-6, TNF-α, IL-8, and activation of the NLRP3 inflammasome pathway 1, 2.
Key Inflammatory Cell Populations
Monocyte-Macrophage Lineage (Primary Driver)
The vast majority of mutated cells in clonal hematopoiesis reside in the myeloid compartment, specifically CD14+ monocytes 2. These cells exhibit:
- Hyperinflammatory activation and differentiation in TET2-mutant clones 1
- Proinflammatory profiles through previously unrecognized pathways including galectin and macrophage inhibitory factor (MIF) signaling 2
- Exacerbated inflammatory responses that reinforce systemic inflammation 1
Hematopoietic Stem and Progenitor Cells (HSPCs)
Interestingly, TET2-mutant HSPCs show opposite behavior compared to their myeloid progeny:
- Blunted transcriptional adaptation to systemic inflammation 1
- Intrinsic epigenetic silencing of AP-1 transcription factors 1
- Dampened inflammatory responsiveness that paradoxically promotes their expansion under inflammatory stress 1
This creates a feed-forward loop: HSPCs with reduced inflammatory responses expand preferentially, while their myeloid progeny drive heightened inflammation.
Specific Cytokines and Chemokines Mediating Inflammation
Pro-inflammatory Cytokines (Upregulated)
The cytokine dysregulation follows a graded pattern (ICUS → MDS → CMML) with widespread upregulation of 3:
- IL-1β - Key inflammasome product
- IL-6 - Major pro-inflammatory mediator
- TNF-α - Drives systemic inflammation
- IL-8 (CXCL8) - Chemokine associated with reduced survival 3
- IL-7, IL-11, IL-15, IL-18 - Various inflammatory roles 3
- CCL7, CXCL11 - Chemokines promoting immune cell recruitment 3
Inflammasome Activation
ASC/NLRP3 double-positive specks are elevated in clonal hematopoiesis, indicating active inflammasome engagement 3. The inflammasome-IL-1 axis represents an actionable therapeutic target 3.
Anti-inflammatory Factors (Suppressed)
Simultaneously, there is suppression of stem and progenitor support factors 3:
- CSF3 (G-CSF)
- FLT3LG
- TRAIL
- TWEAK
This imbalance creates a persistently heightened inflammatory state 4.
Mechanistic Pathways
Pattern Recognition Receptor Activation
Clonal hematopoiesis mutations disturb inflammatory homeostasis through 4:
- Pattern-recognition receptors (PRRs) detecting damage-associated molecular patterns
- Activation of supramolecular organizing centers (SMOCs) including:
- Inflammasome
- Myddosome
- Trifosome
- Necroptosome
- TGF-β pathway
Mutation-Specific Effects
TET2 mutations: Drive hyperinflammatory monocyte-macrophage activation while simultaneously promoting increased stemness in HSPCs through dampened inflammatory responsiveness 1
DNMT3A mutations: Also concentrate in CD14+ monocytes with proinflammatory profiles through galectin and MIF pathways 2
JAK2 mutations: Contribute to pro-inflammatory milieu promoting atherosclerosis and vascular complications 5
Clinical Implications
Systemic Effects
The inflammatory dysregulation extends beyond hematologic compartments:
- Cardiovascular disease acceleration through atherosclerotic mechanisms 5
- Metabolic disorders 4
- Multiple organ system effects from chronic inflammation 4
T-Cell Dysfunction
Although T cells are mostly unmutated in clonal hematopoiesis, they show decreased expression of GTPase of immunity-associated protein genes, suggesting impaired T-cell function as a bystander effect 2.
Important Caveats
The inflammatory signature is mutation-specific: isolated SF3B1 mutations associate with higher inflammasome activation, while other mutation patterns show different cytokine profiles 3. This heterogeneity means not all clonal hematopoiesis drives inflammation equally.
The bidirectional relationship between inflammation and clonal expansion creates a vicious cycle: inflammatory stress conditions induce emergency myelopoiesis that expands TET2-mutant clones, which then produce more inflammation 1.